Home › Sickle Cell Disease › Virginia › Richmond
Sickle Cell Disease clinical trials in Richmond, VA
5 studies for Sickle Cell Disease are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
RecruitingPhase 2
- Virginia Commonwealth University, Richmond
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
RecruitingPhase 3
- VCU Massey Cancer Center: Dalton Oncology Clinic- Site Number : 8400012, Richmond
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Recruiting
- Virginia Commonwealth University, Richmond
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RecruitingPhase 3
- Virginia Comm Univ Medical Ctr, Richmond
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RecruitingPhase 1/2Healthy volunteers welcome
- Virginia Commonwealth University (VCU) Medical Center, Richmond
About Sickle Cell Disease
Sickle cell disease is a group of inherited disorders that affect your red blood cells. It can cause pain, anemia, and other problems. Learn about treatments.
More about Sickle Cell Disease on MedlinePlus
Sickle Cell Disease trials in other cities
- Washington, DC21 studies
- Atlanta, GA20 studies
- Memphis, TN19 studies
- Chicago, IL18 studies
- New York City, NY16 studies
- Philadelphia, PA15 studies
- Birmingham, AL14 studies
- Houston, TX12 studies
- Boston, MA12 studies
- St. Louis, MO12 studies
- Durham, NC10 studies
- Cincinnati, OH10 studies
Other studies in Richmond
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Prostate Cancer19 studies
- Heart Failure17 studies
- Lung Cancer15 studies
- Cardiovascular Disease13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Colorectal Cancer13 studies
- Cancer (all types)12 studies
- Metastatic Cancer12 studies
- Diffuse Large B-Cell Lymphoma11 studies
- Steatotic Liver Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.